Skin cancers in Madagascar: where do we stand?

被引:0
作者
Malalaniaina, Andrianarison [1 ]
Lovasoa, Tika [2 ]
Mamisoa, Ranaivo Irina [3 ]
Malala, Razakanaivo [2 ]
Soavina, Ramarozatovo Lala [4 ]
Florine, Rafaramino [2 ]
Fahafahantsoa, Rapelanoro Rabenja [1 ]
机构
[1] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Dermatol, Antananarivo, Madagascar
[2] Ctr Hosp Univ Joseph Raseta Befelatanana, Serv Oncol, Antananarivo, Madagascar
[3] Ctr Hosp Univ Morafeno, Serv Dermatol, Tamatave, Madagascar
[4] Ctr Hosp Unversitaire Joseph Raseta Befelata, Serv Med Interne & Dermatol, Antananarivo, Madagascar
来源
PAN AFRICAN MEDICAL JOURNAL | 2019年 / 34卷
关键词
Skin cancers; carcinomas; epidemiology; melanoma; Madagascar; MELANOMA; DERMATOLOGY;
D O I
10.11604/pamj.2019.34.167.19269
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: skin cancers are malignant keratinizing tumors of epidermal, melaninic or adnexal origin. These cancers are still little known. However they affect people living in Madagascar where the amount of sunshine remains very high with an impact that varies depending on the skin type. The purpose of our study was to determine the epidemio-clinical profile of skin cancers in Antananarivo. Methods: we conducted a retrospective descriptive study of skin cancers in the Department of Oncology of the Joseph Ravoahangy Andrianavalona Hospital, Antananarivo over a period of seven years. It included patients with tumoral skin lesions confirmed by histological examination. Results: we collected data from 47 cases of skin cancers (male predominance; sex ratio 1.13). The average age of patients was 49.3 years. Farmers were the most affected. The lesions mainly occurred in the head, neck (44%) and lower limbs (42%). Localized skin cancers were detected in 61.7% of cases. Squamous cell carcinoma was the most common skin cancer in Madagascar (37%), followed by the melanoma (21%) and the basal cell carcinoma (11%). Treatment was mainly based on surgery (74.19%). Conclusion: squamous cell carcinoma is the most common cancer in Madagascar, followed by melanoma and basal cell carcinoma. Skin cancers affect mainly the young population and require appropriate management.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] Oncogene-induced senescence and melanoma: where do we stand?
    Peeper, Daniel S.
    PIGMENT CELL & MELANOMA RESEARCH, 2011, 24 (06) : 1107 - 1111
  • [12] The epidemic of Acanthamoeba keratitis: Where do we stand?
    Schaumberg, DA
    Snow, KK
    Dana, MR
    CORNEA, 1998, 17 (01) : 3 - 10
  • [13] HIV and malaria interactions: where do we stand?
    Gonzalez, Raquel
    Ataide, Ricardo
    Naniche, Denise
    Menendez, Clara
    Mayor, Alfredo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (02) : 153 - 165
  • [14] Cutaneous and Mucosal Melanomas of Uncommon Sites: Where Do We Stand Now?
    Dika, Emi
    Lambertini, Martina
    Pellegrini, Cristina
    Veronesi, Giulia
    Melotti, Barbara
    Riefolo, Mattia
    Sperandi, Francesca
    Patrizi, Annalisa
    Ricci, Costantino
    Mussi, Martina
    Fargnoli, Maria Concetta
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (03) : 1 - 15
  • [15] Infectious endocarditis in the case of cirrhosis: where do we stand?
    Allaire, Manon
    Ollivier-Hourmand, Isabelle
    Garioud, Armand
    Heng, Ratmony
    Thong Dao
    Cadranel, Jean-Francois D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (12) : 1406 - 1410
  • [16] Bladder Pain Syndrome: Where Do We Stand Now?
    Chang Kit L.
    Current Bladder Dysfunction Reports, 2014, 9 (1) : 32 - 40
  • [17] Alcohol and cardiovascular diseases: where do we stand today?
    Klatsky, A. L.
    JOURNAL OF INTERNAL MEDICINE, 2015, 278 (03) : 238 - 250
  • [18] Lung cancer in Eastern Morocco: where do we stand?
    Belmokhtar, Karam Yahya
    Tajir, Mariam
    Boulouiz, Redouane
    Bennani, Amal
    Brahmi, Sami Aziz
    Alloubi, Ihsan
    Kouismi, Hatim
    Kamaoui, Imane
    Skiker, Imane
    Afqir, Said
    Abda, Naima
    Bellaoui, Mohammed
    Mezouar, Loubna
    PAN AFRICAN MEDICAL JOURNAL, 2019, 34
  • [19] Immunotherapy in Head and Neck Cancer: Where Do We Stand?
    Vallianou, Natalia G.
    Evangelopoulos, Angelos
    Kounatidis, Dimitris
    Panagopoulos, Fotis
    Geladari, Eleni
    Karampela, Irene
    Stratigou, Theodora
    Dalamaga, Maria
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 897 - 912
  • [20] Pharmacological and interventional management of pulmonary embolism: where do we stand?
    Nagraj, Sanjana
    Li, Weijia
    Zamora, Cristian
    Barakakis, Paraschos Archontakis
    Kokkinidis, Damianos G.
    FUTURE CARDIOLOGY, 2022, 18 (03) : 191 - 206